Prostate cancer and the ProtecT study – The story…
Professor Freddie Hamdy is Head of Department at the Nuffield Department of Surgical Sciences, and the Chief Investigator of The ProtecT Trial – the first trial to evaluate the effectiveness, cost-effectiveness and acceptability of three major treatment options: active monitoring, surgery (radical prostatectomy) and radiotherapy for men with localised prostate cancer.

In September 2016, Professor Hamdy and his team published the first results of their 10 year study and made international headlines. A trial of 1,643 men with small prostate cancers resulted in the same 99% survival rate after a decade for those who had had surgery, radiotherapy or simply monitored the tumour.
Date: 14 October 2016, 8:00 (Friday, 1st week, Michaelmas 2016)
Venue: John Radcliffe Academic, Headington OX3 9DU
Venue Details: Lecture Theatre 1
Speaker: Professor Freddie Hamdy (University of Oxford, Nuffield Department of Surgical Sciences)
Organising department: Nuffield Department of Surgical Sciences
Organiser: Tarryn Ching (University of Oxford, Nuffield Department of Surgical Sciences)
Organiser contact email address: tarryn.ching@nds.ox.ac.uk
Host: Professor Freddie Hamdy (University of Oxford, Nuffield Department of Surgical Sciences)
Part of: Surgical Grand Rounds
Topics: Urology
Booking required?: Not required
Audience: Members of the University only
Editor: Louise King